Michael Cohen is a Neurology physician. ClinicalTrials.gov lists 8 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1501 Trousdale Dr
4th Floor
Burlingame, CA 940104506
Telephone
650-652-8500Provider last certified this registry record 22 Jun 2020.
Clinical trials
- Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia
Sponsor: Melinta Therapeutics, Inc.
- PK of Clindamycin and Trimethoprim-sulfamethoxazole in Infants and Children
Sponsor: Michael Cohen-Wolkowiez
- Use of Amplification in Children With Unilateral Hearing Loss
Sponsor: Massachusetts Eye and Ear Infirmary
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- UCB, Inc.Program year20254 payments
- Genentech USA, Inc.Program year20241 payment
- SK Life Science, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
92%Aromatic Amino Acid Decarboxylation Inhibitor16.1%Carbidopa-Levodopa71%Carbidopa-Levodopa Er20%Rytary6%Carbidopa-Levodopa-Entacapone4%Part D<11 patientsGabapentinoids15.4%Gabapentin85%Pregabalin15%Part D≥120 patients+ 21 more classes in this area
Musculoskeletal
2.3%gamma-Aminobutyric Acid-ergic Agonist1.1%Baclofen100%Part D<11 patientsCentral alpha-2 Adrenergic Agonist0.5%Tizanidine Hcl100%Part D<11 patients+ 2 more classes in this area
Cardiovascular
1.8%Beta blocker1.3%Propranolol Hcl Er53%Propranolol Hcl47%Part D<11 patientsalpha-Adrenergic Agonist0.5%Midodrine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2005–2015 per NIH RePORTER. The latest:
- Neural Mechanisms Underlying Enhanced Memory for Valuable Items in Healthy Aging
University of California Los Angeles
FY2015$11,779F31AG047048 - Neural Mechanisms Underlying Enhanced Memory for Valuable Items in Healthy Aging
University of California Los Angeles
FY2014$34,219F31AG047048 - Age-dependent changes in motor learning capabilities
California State University Long Beach
FY2009$139,966R01AG025091
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”